| Trade Date |
Insider |
Title |
Buy or Sell |
Quantity |
Security Type |
Price |
Proceeds |
Transaction Conviction |
Position Quantity |
Position Value |
Positon Conviction |
SEC Link |
Nature of Ownership |
2020-04-27 | Manner Carrie Eglinton | SVP, Advanced Diagnostics | Sell | 2,500 | Common Stock | $112.03 | $280,075.00 | 0.19 [ Low ] | 24,890 | $2,788,426.70 | 1.86 [Low] | Form 4 | - | 2020-04-27 | Manner Carrie Eglinton | SVP, Advanced Diagnostics | Sell | 2,500 | Common Stock | $110.00 | $275,000.00 | 0.19 [ Low ] | 22,390 | $2,462,900.00 | 1.67 [Low] | Form 4 | - | 2020-04-27 | Stephen H Rusckowski | Chairman, CEO and President | Buy | 11,717 | Common Stock | $71.17 | -$833,898.89 | 0.88 [ High ] | 249,464 | $17,754,352.88 | 18.65 [High] | Form 4 | - | 2020-04-27 | Stephen H Rusckowski | Chairman, CEO and President | Sell | 11,717 | Common Stock | $112.01 | $1,312,421.17 | 0.88 [ High ] | 237,747 | $26,630,041.47 | 17.78 [High] | Form 4 | - | 2020-05-18 | Michael J Deppe | VP, Corp. Controller & CAO | Sell | 5 | Common Stock | $107.42 | $537.10 | - | 25,035 | $2,689,259.70 | 1.87 [Low] | Form 4 | - | 2020-05-19 | Gail R Wilensky | - | Buy | 1,531 | Common Stock | $0.00 | $0.00 | - | 16,482 | $0.00 | 1.23 [Very Low] | Form 4 | - | 2020-05-19 | Denise M Morrison | - | Buy | 1,531 | Common Stock | $0.00 | $0.00 | - | 3,783 | $0.00 | 0.28 [Very Low] | Form 4 | - | 2020-05-19 | Vicky B Gregg | - | Buy | 1,531 | Common Stock | $0.00 | $0.00 | - | 13,844 | $0.00 | 1.04 [Very Low] | Form 4 | - | 2020-05-19 | Helen Torley | - | Buy | 1,531 | Common Stock | $0.00 | $0.00 | - | 4,897 | $0.00 | 0.37 [Very Low] | Form 4 | - | 2020-05-19 | Timothy L Main | - | Buy | 1,531 | Common Stock | $0.00 | $0.00 | - | 19,588 | $0.00 | 1.46 [Low] | Form 4 | - | 2020-05-19 | Gary M Pfeiffer | - | Buy | 1,531 | Common Stock | $0.00 | $0.00 | - | 21,513 | $0.00 | 1.61 [Low] | Form 4 | - | 2020-05-19 | Timothy M Ring | - | Buy | 1,531 | Common Stock | $0.00 | $0.00 | - | 20,505 | $0.00 | 1.53 [Low] | Form 4 | - | 2020-05-19 | Daniel Stanzione | - | Buy | 1,531 | Common Stock | $0.00 | $0.00 | - | 39,572 | $0.00 | 2.96 [Low] | Form 4 | - | 2020-05-19 | Wright Iii Lassiter | - | Buy | 1,531 | Common Stock | $0.00 | $0.00 | - | 1,882 | $0.00 | 0.14 [Very Low] | Form 4 | - | 2020-06-08 | Timothy M Ring | - | Buy | 2,547 | Common Stock | $57.74 | -$147,063.78 | - | 23,052 | $1,331,022.48 | - | Form 4 | - | 2020-06-08 | Timothy M Ring | - | Buy | 532 | Common Stock | $58.37 | -$31,052.84 | - | 23,584 | $1,376,598.08 | - | Form 4 | - | 2020-06-08 | Timothy M Ring | - | Buy | 151 | Common Stock | $58.37 | -$8,813.87 | - | 23,735 | $1,385,411.95 | - | Form 4 | - | 2020-06-08 | Timothy M Ring | - | Buy | 820 | Common Stock | $61.62 | -$50,528.40 | - | 24,555 | $1,513,079.10 | - | Form 4 | - | 2020-06-08 | Timothy M Ring | - | Buy | 6,111 | Common Stock | $57.56 | -$351,749.16 | - | 30,666 | $1,765,134.96 | - | Form 4 | - | 2020-06-08 | Timothy M Ring | - | Buy | 790 | Common Stock | $60.22 | -$47,573.80 | - | 31,456 | $1,894,280.32 | - | Form 4 | - | 2020-06-08 | Timothy M Ring | - | Buy | 779 | Common Stock | $63.42 | -$49,404.18 | - | 32,235 | $2,044,343.70 | - | Form 4 | - | 2020-06-08 | Timothy M Ring | - | Sell | 11,730 | Common Stock | $116.60 | $1,367,718.00 | - | 20,505 | $2,390,883.00 | - | Form 4 | - | 2020-06-08 | Mark Guinan | Executive Vice President & CFO | Buy | 72,596 | Common Stock | $71.17 | -$5,166,657.32 | - | 146,175 | $10,403,274.75 | - | Form 4 | - | 2020-06-08 | Mark Guinan | Executive Vice President & CFO | Sell | 45,826 | Common Stock | $116.81 | $5,352,935.06 | - | 100,349 | $11,721,766.69 | - | Form 4 | - | 2020-06-08 | Mark Guinan | Executive Vice President & CFO | Sell | 18,246 | Common Stock | $117.65 | $2,146,641.90 | - | 82,103 | $9,659,417.95 | - | Form 4 | - | 2020-06-08 | Mark Guinan | Executive Vice President & CFO | Sell | 8,524 | Common Stock | $118.60 | $1,010,946.40 | - | 73,579 | $8,726,469.40 | - | Form 4 | - | 2020-09-02 | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Buy | 58,392 | Common Stock | $66.51 | -$3,883,651.92 | 4.35 [ Very High ] | 126,803 | $8,433,667.53 | 9.44 [Average] | Form 4 | - | 2020-09-02 | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sell | 54,616 | Common Stock | $110.57 | $6,038,891.12 | 4.07 [ Very High ] | 72,187 | $7,981,716.59 | 5.37 [Average] | Form 4 | - | 2020-09-02 | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sell | 3,776 | Common Stock | $111.13 | $419,626.88 | 0.28 [ Low ] | 68,411 | $7,602,514.43 | 5.09 [Average] | Form 4 | - | 2020-10-06 | Manuel O. Mendez | SVP & Chief Commercial Officer | Sell | 5,871 | Common Stock | $114.01 | $669,352.71 | 0.44 [ Average ] | 23,982 | $2,734,187.82 | 1.79 [Low] | Form 4 | - | 2020-10-14 | Michael E Prevoznik | SVP & General Counsel | Buy | 35,591 | Common Stock | $52.16 | -$1,856,426.56 | 2.65 [ Very High ] | 75,678 | $3,947,364.48 | 5.63 [Average] | Form 4 | - | 2020-10-14 | Michael E Prevoznik | SVP & General Counsel | Sell | 35,591 | Common Stock | $119.00 | $4,235,329.00 | 2.65 [ Very High ] | 40,087 | $4,770,353.00 | 2.98 [Low] | Form 4 | - | 2020-10-16 | Stephen H Rusckowski | Chairman, CEO and President | Buy | 291,997 | Common Stock | $66.51 | -$19,420,720.47 | 21.74 [ Very High ] | 529,744 | $35,233,273.44 | 39.44 [High] | Form 4 | - | 2020-10-16 | Stephen H Rusckowski | Chairman, CEO and President | Sell | 291,997 | Common Stock | $120.00 | $35,039,640.00 | 21.74 [ Very High ] | 237,747 | $28,529,640.00 | 17.70 [High] | Form 4 | - | 2020-10-21 | Michael J Deppe | VP, Corp. Controller & CAO | Buy | 4,750 | Common Stock | $56.82 | -$269,895.00 | 0.35 [ Average ] | 29,785 | $1,692,383.70 | 2.22 [Low] | Form 4 | - | 2020-10-21 | Michael J Deppe | VP, Corp. Controller & CAO | Buy | 5,700 | Common Stock | $57.60 | -$328,320.00 | 0.42 [ Average ] | 35,485 | $2,043,936.00 | 2.64 [Low] | Form 4 | - | 2020-10-21 | Michael J Deppe | VP, Corp. Controller & CAO | Sell | 5,700 | Common Stock | $125.00 | $712,500.00 | 0.42 [ Average ] | 29,785 | $3,723,125.00 | 2.22 [Low] | Form 4 | - | 2020-10-21 | Michael J Deppe | VP, Corp. Controller & CAO | Sell | 4,750 | Common Stock | $125.00 | $593,750.00 | 0.35 [ Average ] | 25,090 | $3,136,250.00 | 1.87 [Low] | Form 4 | - | 2020-11-23 | Daniel Stanzione | - | Sell | 5,621 | Common Stock | $125.73 | $706,728.33 | 0.42 [ Average ] | 33,951 | $4,268,659.23 | 2.52 [Low] | Form 4 | - | 2020-11-23 | Daniel Stanzione | - | Sell | 3,302 | Common Stock | $126.46 | $417,570.92 | 0.25 [ Low ] | 30,649 | $3,875,872.54 | 2.27 [Low] | Form 4 | - | 2020-11-23 | Daniel Stanzione | - | Sell | 2,300 | Common Stock | $127.45 | $293,135.00 | 0.17 [ Low ] | 28,349 | $3,613,080.05 | 2.10 [Low] | Form 4 | - | 2020-11-24 | Gail R Wilensky | - | Buy | 6,111 | Common Stock | $57.66 | -$352,360.26 | 0.45 [ Average ] | 22,593 | $1,302,712.38 | 1.68 [Low] | Form 4 | - | 2020-11-24 | Gail R Wilensky | - | Sell | 6,111 | Common Stock | $126.02 | $770,108.22 | 0.45 [ Average ] | 16,482 | $2,077,061.64 | 1.22 [Very Low] | Form 4 | - | 2020-12-24 | Mark Guinan | Executive Vice President & CFO | Buy | 81,756 | Common Stock | $66.51 | -$5,437,591.56 | 6.07 [ Very High ] | 155,335 | $10,331,330.85 | 11.53 [Average] | Form 4 | - | 2020-12-24 | Mark Guinan | Executive Vice President & CFO | Sell | 59,193 | Common Stock | $120.06 | $7,106,711.58 | 4.39 [ Very High ] | 96,142 | $11,542,808.52 | 7.13 [Average] | Form 4 | - | 2020-12-24 | Mark Guinan | Executive Vice President & CFO | Sell | 22,563 | Common Stock | $121.18 | $2,734,184.34 | 1.67 [ High ] | 73,579 | $8,916,303.22 | 5.46 [Average] | Form 4 | - | 2021-01-04 | Manner Carrie Eglinton | SVP, Advanced Diagnostics | Sell | 2,640 | Common Stock | $119.00 | $314,160.00 | 0.20 [ Low ] | 19,896 | $2,367,624.00 | 1.48 [Low] | Form 4 | - | 2021-02-17 | Manner Carrie Eglinton | SVP, Advanced Diagnostics | Buy | 4,926 | Common Stock | $0.00 | $0.00 | - | 24,841 | $0.00 | 1.87 [Low] | Form 4 | - | 2021-02-17 | J. E. Davis | EVP, General Diagnostics | Buy | 5,665 | Common Stock | $0.00 | $0.00 | - | 43,751 | $0.00 | 3.29 [Low] | Form 4 | - | 2021-02-17 | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Buy | 3,941 | Common Stock | $0.00 | $0.00 | - | 72,352 | $0.00 | 5.44 [Average] | Form 4 | - | 2021-02-17 | Mark Guinan | Executive Vice President & CFO | Buy | 5,665 | Common Stock | $0.00 | $0.00 | - | 79,244 | $0.00 | 5.96 [Average] | Form 4 | - | 2021-02-17 | Michael J Deppe | VP, Corp. Controller & CAO | Buy | 715 | Common Stock | $0.00 | $0.00 | - | 25,863 | $0.00 | 1.94 [Low] | Form 4 | - | 2021-02-17 | Michael E Prevoznik | SVP & General Counsel | Buy | 3,202 | Common Stock | $0.00 | $0.00 | - | 43,289 | $0.00 | 3.25 [Low] | Form 4 | - | 2021-02-17 | Stephen H Rusckowski | Chairman, CEO and President | Buy | 21,551 | Common Stock | $0.00 | $0.00 | - | 259,298 | $0.00 | 19.50 [High] | Form 4 | - | 2021-02-17 | Manuel O. Mendez | SVP & Chief Commercial Officer | Buy | 4,926 | Common Stock | $0.00 | $0.00 | - | 29,045 | $0.00 | 2.18 [Low] | Form 4 | - | 2021-02-23 | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sell | 796 | Common Stock | $121.15 | $96,435.40 | 0.06 [ Very Low ] | 71,556 | $8,669,009.40 | 5.36 [Average] | Form 4 | - | 2021-02-24 | Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sell | 524 | Common Stock | $121.19 | $63,503.56 | 0.04 [ Very Low ] | 71,032 | $8,608,368.08 | 5.32 [Average] | Form 4 | - | 2021-02-23 | Stephen H Rusckowski | Chairman, CEO and President | Sell | 4,033 | Common Stock | $121.15 | $488,597.95 | 0.30 [ Average ] | 255,265 | $30,925,354.75 | 19.13 [High] | Form 4 | - | 2021-02-24 | Stephen H Rusckowski | Chairman, CEO and President | Sell | 3,319 | Common Stock | $121.19 | $402,229.61 | 0.25 [ Low ] | 251,946 | $30,533,335.74 | 18.88 [High] | Form 4 | - | 2021-02-23 | Mark Guinan | Executive Vice President & CFO | Sell | 830 | Common Stock | $121.15 | $100,554.50 | 0.06 [ Very Low ] | 78,414 | $9,499,856.10 | 5.88 [Average] | Form 4 | - | 2021-02-24 | Mark Guinan | Executive Vice President & CFO | Sell | 541 | Common Stock | $121.19 | $65,563.79 | 0.04 [ Very Low ] | 77,873 | $9,437,428.87 | 5.84 [Average] | Form 4 | - | 2021-02-23 | Manner Carrie Eglinton | SVP, Advanced Diagnostics | Sell | 1,017 | Common Stock | $121.15 | $123,209.55 | 0.08 [ Very Low ] | 23,824 | $2,886,277.60 | 1.79 [Low] | Form 4 | - | 2021-02-24 | Manner Carrie Eglinton | SVP, Advanced Diagnostics | Sell | 611 | Common Stock | $121.19 | $74,047.09 | 0.05 [ Very Low ] | 23,213 | $2,813,183.47 | 1.74 [Low] | Form 4 | - | 2021-02-23 | Michael J Deppe | VP, Corp. Controller & CAO | Sell | 159 | Common Stock | $121.15 | $19,262.85 | - | 25,704 | $3,114,039.60 | 1.93 [Low] | Form 4 | - | 2021-02-24 | Michael J Deppe | VP, Corp. Controller & CAO | Sell | 103 | Common Stock | $121.19 | $12,482.57 | - | 25,601 | $3,102,585.19 | 1.92 [Low] | Form 4 | - | 2021-02-23 | Michael E Prevoznik | SVP & General Counsel | Sell | 693 | Common Stock | $121.15 | $83,956.95 | 0.05 [ Very Low ] | 42,596 | $5,160,505.40 | 3.19 [Low] | Form 4 | - | 2021-02-24 | Michael E Prevoznik | SVP & General Counsel | Sell | 455 | Common Stock | $121.19 | $55,141.45 | 0.03 [ Very Low ] | 42,141 | $5,107,067.79 | 3.16 [Low] | Form 4 | - | 2021-02-24 | Michael E Prevoznik | SVP & General Counsel | Sell | 438 | Common Stock | $116.95 | $51,224.10 | 0.03 [ Very Low ] | 41,703 | $4,877,165.85 | 3.12 [Low] | Form 4 | - | 2021-02-24 | Michael E Prevoznik | SVP & General Counsel | Sell | 750 | Common Stock | $116.95 | $87,712.50 | 0.06 [ Very Low ] | 40,953 | $4,789,453.35 | 3.07 [Low] | Form 4 | - | 2021-02-23 | J. E. Davis | EVP, General Diagnostics | Sell | 1,250 | Common Stock | $121.15 | $151,437.50 | 0.09 [ Very Low ] | 42,501 | $5,148,996.15 | 3.18 [Low] | Form 4 | - | 2021-02-24 | J. E. Davis | EVP, General Diagnostics | Sell | 806 | Common Stock | $121.19 | $97,679.14 | 0.06 [ Very Low ] | 41,695 | $5,053,017.05 | 3.12 [Low] | Form 4 | - | 2021-02-25 | Michael E Prevoznik | SVP & General Counsel | Sell | 801 | Common Stock | $115.49 | $92,507.49 | 0.06 [ Very Low ] | 40,152 | $4,637,154.48 | 3.01 [Low] | Form 4 | - |
